DWCox: A density-weighted Cox model for outlier-robust prediction of prostate cancer survival
- PMID: 28299178
- PMCID: PMC5321125
- DOI: 10.12688/f1000research.9434.1
DWCox: A density-weighted Cox model for outlier-robust prediction of prostate cancer survival
Abstract
Reliable predictions on the risk and survival time of prostate cancer patients based on their clinical records can help guide their treatment and provide hints about the disease mechanism. The Cox regression is currently a commonly accepted approach for such tasks in clinical applications. More complex methods, like ensemble approaches, have the potential of reaching better prediction accuracy at the cost of increased training difficulty and worse result interpretability. Better performance on a specific data set may also be obtained by extensive manual exploration in the data space, but such developed models are subject to overfitting and usually not directly applicable to a different data set. We propose DWCox, a density-weighted Cox model that has improved robustness against outliers and thus can provide more accurate predictions of prostate cancer survival. DWCox assigns weights to the training data according to their local kernel density in the feature space, and incorporates those weights into the partial likelihood function. A linear regression is then used to predict the actual survival times from the predicted risks. In the 2015 Prostate Cancer DREAM Challenge, DWCox obtained the best average ranking in prediction accuracy on the risk and survival time. The success of DWCox is remarkable given that it is one of the smallest and most interpretable models submitted to the challenge. In simulations, DWCox performed consistently better than a standard Cox model when the training data contained many sparsely distributed outliers. Although developed for prostate cancer patients, DWCox can be easily re-trained and applied to other survival analysis problems. DWCox is implemented in R and can be downloaded from https://github.com/JinfengXiao/DWCox.
Keywords: Cox model; DREAM; Prostate cancer.
Conflict of interest statement
Competing interests: No competing interests were disclosed.
Figures








Similar articles
-
An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients.F1000Res. 2016 Nov 16;5:2677. doi: 10.12688/f1000research.8226.1. eCollection 2016. F1000Res. 2016. PMID: 28413609 Free PMC article.
-
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.Lancet Oncol. 2017 Jan;18(1):132-142. doi: 10.1016/S1470-2045(16)30560-5. Epub 2016 Nov 16. Lancet Oncol. 2017. PMID: 27864015 Free PMC article. Clinical Trial.
-
Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach.F1000Res. 2016 Nov 16;5:2672. doi: 10.12688/f1000research.8628.1. eCollection 2016. F1000Res. 2016. PMID: 28299176 Free PMC article.
-
Comparison of methods for the detection of outliers and associated biomarkers in mislabeled omics data.BMC Bioinformatics. 2020 Aug 14;21(1):357. doi: 10.1186/s12859-020-03653-9. BMC Bioinformatics. 2020. PMID: 32795265 Free PMC article.
-
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients.F1000Res. 2016 Nov 16;5:2676. doi: 10.12688/f1000research.8231.3. eCollection 2016. F1000Res. 2016. PMID: 28713544 Free PMC article.
References
-
- Garcia M, Jemal A, Ward EM, et al. : Global cancer facts & figures 2007. Atlanta, GA: American cancer society. 2007;1(3):52 Reference Source
-
- Cox DR: Regression models and life-tables. In Breakthroughs in statistics.Springer,1992;527–541. 10.1007/978-1-4612-4380-9_37 - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources